SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-039352
Filing Date
2015-02-09
Accepted
2015-02-09 17:20:35
Documents
1
Period of Report
2015-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d868765d8k.htm 8-K 12452
  Complete submission text file 0001193125-15-039352.txt   13586
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23155 | Film No.: 15589500
SIC: 2836 Biological Products, (No Diagnostic Substances)